Oteseconazole for yeast infection treatment
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests a new antifungal medicine (oteseconazole) for women with a moderate to severe yeast infection. It aims to see if the drug works well and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female aged 18 or older.
- You have moderate to severe vulvovaginal symptoms (like itching, burning, or discharge).
- You plan to use the study medication oteseconazole (either alone or with other drugs).
- You are not pregnant or breastfeeding.
- You are not currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This study compares how well a new vaginal yeast (Candida) test matches a standard yeast culture test. It may help clinicians choose the most accurate, convenient way to tell whether vaginal symptoms are caused by yeast.
This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.
Hear when a new Vulvovaginal Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.